A presentation at the 26th annual meeting of the European Association of Urology in 2011 [43] revealed that serum levels of proinflammatory cytokines, including TNF-α, increased 2 days after administration of docetaxel to patients with castration-resistant prostate cancer. The gene discussed is TNF; the disease is prostate cancer.